Semler Scientific, Inc. (SMLR) 10-Year Financial Performance & Capital Metrics

SMLR • • Industrial / General

HealthcareMedical DevicesDiagnostic & Imaging EquipmentPoint-of-Care Diagnostics

AboutSemler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.Show more

Revenue $56M -17.4%
EBITDA $22M -5.9%
Net Income $41M +98.7%
EPS (Diluted) 5.13 +95.1%
Gross Margin 91.55% +2.0%
EBITDA Margin 38.21% +14.0%
Operating Margin 37.19% +13.9%
Net Margin 72.65% +140.7%
ROE 27.04% -16.3%
ROIC 13.26% -81.1%
Debt/Equity 0.00 -86.4%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 29.2%
✓Strong 5Y profit CAGR of 22.1%
✓Strong 5Y sales CAGR of 11.4%
✓Healthy 5Y average net margin of 39.4%
✓Trading at only 0.7x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 12 (bottom 12%)
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y31.52%

5Y11.43%

3Y2.01%

TTM-37.29%

Profit (Net Income) CAGR

10Y-

5Y22.08%

3Y33.42%

TTM203.75%

EPS CAGR

10Y-

5Y22.23%

3Y34.25%

TTM35.52%

ROCE

10Y Avg-5.61%

5Y Avg41.51%

3Y Avg27.47%

Latest13.71%

Peer Comparison

Point-of-Care Diagnostics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
PAVMPAVmed Inc.	8.06M	8.75	17.64	22.15%	-217914.55%	-245.07%
SMLRSemler Scientific, Inc.	310.75M	20.33	3.96	-17.44%	130.8%	10.51%	0.00
BJDXBluejay Diagnostics, Inc.	1.18M	0.65	-0.02			-185.51%	0.04
HSCSHeartSciences Inc.	10.17M	3.20	-0.34	-76.61%	-1042.38%	-216.05%	14.55
LUCDLucid Diagnostics Inc.	163.87M	1.25	-1.19	79%	-8.6%	-404.1%	3.94
BMRABiomerica, Inc.	8.09M	2.68	-1.24	-1.92%	-90.29%	-90.76%	0.11
MDAISpectral AI, Inc.	49.41M	1.61	-1.89	63.83%	-70.64%
CODXCo-Diagnostics, Inc.	6.12M	2.92	-2.35	-42.53%	-63.36%	-80.8%	0.04

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	7M	7.43M	12.45M	21.49M	32.77M	38.6M	53.03M	56.69M	68.18M	56.29M
Revenue Growth %	0.93%	0.06%	0.68%	0.73%	0.52%	0.18%	0.37%	0.07%	0.2%	-0.17%
Cost of Goods Sold+	2.85M	1.87M	2.55M	2.7M	3.66M	3.36M	6.12M	4.25M	6.98M	4.76M
COGS % of Revenue	0.41%	0.25%	0.21%	0.13%	0.11%	0.09%	0.12%	0.08%	0.1%	0.08%
Gross Profit+	4.15M	5.56M	9.9M	18.79M	29.11M	35.25M	46.91M	52.43M	61.2M	51.53M
Gross Margin %	0.59%	0.75%	0.79%	0.87%	0.89%	0.91%	0.88%	0.92%	0.9%	0.92%
Gross Profit Growth %	0.41%	0.34%	0.78%	0.9%	0.55%	0.21%	0.33%	0.12%	0.17%	-0.16%
Operating Expenses+	12.57M	7.72M	10.75M	13.45M	18.4M	19.29M	27.46M	35.23M	38.94M	30.6M
OpEx % of Revenue	1.8%	1.04%	0.86%	0.63%	0.56%	0.5%	0.52%	0.62%	0.57%	0.54%
Selling, General & Admin	11.14M	6.85M	8.92M	11.36M	15.92M	16.35M	23.68M	30.42M	32.44M	25.81M
SG&A % of Revenue	1.59%	0.92%	0.72%	0.53%	0.49%	0.42%	0.45%	0.54%	0.48%	0.46%
Research & Development	1.44M	866K	1.83M	2.08M	2.48M	2.94M	3.78M	4.81M	5.77M	4.79M
R&D % of Revenue	0.21%	0.12%	0.15%	0.1%	0.08%	0.08%	0.07%	0.08%	0.08%	0.09%
Other Operating Expenses	-82K	0	-14K	-4K	-9K	0	0	0	734K	0
Operating Income+	-8.42M	-2.16M	-853K	5.34M	10.71M	15.96M	19.45M	17.2M	22.26M	20.93M
Operating Margin %	-1.2%	-0.29%	-0.07%	0.25%	0.33%	0.41%	0.37%	0.3%	0.33%	0.37%
Operating Income Growth %	-0.94%	0.74%	0.6%	7.26%	1%	0.49%	0.22%	-0.12%	0.29%	-0.06%
EBITDA+	-8.1M	-1.71M	-294K	5.84M	11.34M	16.54M	20.07M	17.79M	22.86M	21.51M
EBITDA Margin %	-1.16%	-0.23%	-0.02%	0.27%	0.35%	0.43%	0.38%	0.31%	0.34%	0.38%
EBITDA Growth %	-0.96%	0.79%	0.83%	20.88%	0.94%	0.46%	0.21%	-0.11%	0.28%	-0.06%
D&A (Non-Cash Add-back)	315K	452K	559K	503K	632K	577K	622K	589K	599K	579K
EBIT	-8.41M	-2.16M	-1.05M	5.34M	10.71M	16.49M	19.45M	17.2M	22.99M	20.93M
Net Interest Income+	-86K	-391K	-464K	-298K	2K	19K	10K	494K	2.47M	1.88M
Interest Income	0	0	0	0	2K	19K	10K	494K	2.47M	1.88M
Interest Expense	86K	391K	464K	298K	0	0	0	0	0	0
Other Income/Expense	-82K	-395K	-657K	-302K	-7K	525K	10K	489K	1.84M	26.95M
Pretax Income+	-8.5M	-2.55M	-1.51M	5.04M	10.7M	16.49M	19.45M	17.69M	24.1M	47.88M
Pretax Margin %	-1.21%	-0.34%	-0.12%	0.23%	0.33%	0.43%	0.37%	0.31%	0.35%	0.85%
Income Tax+	0	0	0	26K	-4.38M	2.48M	2.23M	3.37M	3.52M	6.99M
Effective Tax Rate %	1%	1%	1%	0.99%	1.41%	0.85%	0.89%	0.81%	0.85%	0.85%
Net Income+	-8.5M	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M
Net Margin %	-1.21%	-0.34%	-0.12%	0.23%	0.46%	0.36%	0.32%	0.25%	0.3%	0.73%
Net Income Growth %	-0.88%	0.7%	0.41%	4.32%	2.01%	-0.07%	0.23%	-0.17%	0.44%	0.99%
Net Income (Continuing)	-8.5M	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-1.72	-0.50	-0.28	0.66	1.88	1.74	2.12	1.79	2.63	5.13
EPS Growth %	-0.56%	0.71%	0.44%	3.36%	1.85%	-0.07%	0.22%	-0.16%	0.47%	0.95%
EPS (Basic)	-1.72	-0.50	-0.28	0.66	2.34	2.13	2.56	2.13	3.06	5.66
Diluted Shares Outstanding	4.93M	5.12M	5.41M	7.63M	8.03M	8.07M	8.14M	8M	7.82M	7.98M
Basic Shares Outstanding	4.93M	5.12M	5.39M	7.6M	6.44M	6.58M	6.73M	6.73M	6.73M	7.23M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.75M	1.59M	2.88M	6.24M	11.44M	26.6M	45.54M	48.91M	65.94M	22.69M
Cash & Short-Term Investments	405K	622K	1.46M	3.28M	7.74M	22.08M	37.32M	43.09M	57.2M	14.92M
Cash Only	405K	622K	1.46M	3.28M	7.74M	22.08M	37.32M	23.01M	57.2M	8.82M
Short-Term Investments	0	0	0	0	0	0	0	20.07M	0	6.1M
Accounts Receivable	1.28M	877K	1.31M	2.8M	3.49M	2.81M	3.62M	3.88M	6.13M	4.38M
Days Sales Outstanding	66.63	43.06	38.55	47.57	38.83	26.55	24.91	25.01	32.79	28.39
Inventory	-1.28M	-877K	-1.31M	-2.8M	0	340K	550K	469K	445K	358K
Days Inventory Outstanding	-	-	-	-	-	36.98	32.79	40.26	23.26	27.46
Other Current Assets	0	0	0	0	0	0	0	0	2.17M	3.03M
Total Non-Current Assets+	1.33M	1.48M	1.35M	1.48M	6.84M	8.04M	5.14M	13.79M	12.12M	217.14M
Property, Plant & Equipment	1.33M	1.47M	1.34M	1.47M	2.33M	2.2M	2.04M	3.15M	3M	1.91M
Fixed Asset Turnover	5.28x	5.07x	9.29x	14.66x	14.08x	17.53x	26.03x	18.02x	22.69x	29.47x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	214.63M
Long-Term Investments	0	0	0	0	0	3.05M	821K	5.5M	5.88M	512K
Other Non-Current Assets	0	15K	15K	15K	15K	418K	332K	2.84M	270K	85K
Total Assets+	3.08M	3.07M	4.24M	7.72M	18.29M	34.64M	50.67M	62.69M	78.06M	239.83M
Asset Turnover	2.27x	2.42x	2.94x	2.78x	1.79x	1.11x	1.05x	0.90x	0.87x	0.23x
Asset Growth %	-0.59%	-0%	0.38%	0.82%	1.37%	0.89%	0.46%	0.24%	0.25%	2.07%
Total Current Liabilities+	4.11M	3.23M	5.14M	3.51M	5.21M	4.51M	4.88M	6.86M	6.2M	6.31M
Accounts Payable	839K	450K	488K	280K	338K	677K	443K	835K	402K	140K
Days Payables Outstanding	107.56	87.69	69.77	37.81	33.7	73.63	26.41	71.68	21.01	10.74
Short-Term Debt	0	81K	1.25M	0	0	0	0	0	0	0
Deferred Revenue (Current)	952K	513K	531K	435K	955K	963K	921K	1000K	1000K	774K
Other Current Liabilities	1.09M	704K	591K	355K	1.04M	1.6M	523K	2.5M	2.09M	3.9M
Current Ratio	0.43x	0.49x	0.56x	1.78x	2.20x	5.89x	9.33x	7.13x	10.64x	3.59x
Quick Ratio	0.74x	0.76x	0.82x	2.57x	2.20x	5.82x	9.22x	7.06x	10.56x	3.54x
Cash Conversion Cycle	-	-	-	-	-	-10.1	31.29	-6.41	35.04	45.11
Total Non-Current Liabilities+	43K	2.76M	1.68M	11K	7K	332K	245K	160K	70K	2.77M
Long-Term Debt	0	2.53M	1.67M	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	245K	160K	70K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	2.77M
Other Non-Current Liabilities	43K	230K	13K	11K	7K	332K	0	0	0	0
Total Liabilities	4.15M	5.99M	6.82M	3.52M	5.21M	4.85M	5.13M	7.02M	6.27M	9.08M
Total Debt+	0	2.61M	2.92M	0	0	0	325K	245K	160K	70K
Net Debt	-405K	1.99M	1.47M	-3.28M	-7.74M	-22.08M	-37M	-22.77M	-57.04M	-8.75M
Debt / Equity	-	-	-	-	-	-	0.01x	0.00x	0.00x	0.00x
Debt / EBITDA	-	-	-	-	-	-	0.02x	0.01x	0.01x	0.00x
Net Debt / EBITDA	-	-	-	-0.56x	-0.68x	-1.34x	-1.84x	-1.28x	-2.50x	-0.41x
Interest Coverage	-97.90x	-5.52x	-1.84x	17.93x	-	-	-	-	-	-
Total Equity+	-1.07M	-2.92M	-2.58M	4.2M	13.07M	29.79M	45.55M	55.68M	71.8M	230.75M
Equity Growth %	-1.31%	-1.72%	0.12%	2.62%	2.12%	1.28%	0.53%	0.22%	0.29%	2.21%
Book Value per Share	-0.22	-0.57	-0.48	0.55	1.63	3.69	5.60	6.96	9.18	28.92
Total Shareholders' Equity	-1.07M	-2.92M	-2.58M	4.2M	13.07M	29.79M	45.55M	55.68M	71.8M	230.75M
Common Stock	5K	5K	6K	6K	7K	7K	7K	7K	7K	9K
Retained Earnings	-22.37M	-24.92M	-26.43M	-21.42M	-6.33M	7.67M	24.89M	39.22M	59.8M	100.7M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-495K	-656K	-829K	-234K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-4.13M	-1.8M	621K	4.7M	12.73M	15.11M	16.06M	17.46M	17.82M	24.41M
Operating CF Margin %	-0.59%	-0.24%	0.05%	0.22%	0.39%	0.39%	0.3%	0.31%	0.26%	0.43%
Operating CF Growth %	-0.08%	0.56%	1.34%	6.56%	1.71%	0.19%	0.06%	0.09%	0.02%	0.37%
Net Income	-8.5M	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M
Depreciation & Amortization	315K	452K	559K	503K	632K	576K	628K	589K	599K	579K
Stock-Based Compensation	2.6M	300K	343K	601K	0	253K	749K	741K	0	862K
Deferred Taxes	416K	331K	718K	246K	-4.5M	2.14M	408K	-351K	-664K	5.73M
Other Non-Cash Items	55K	185K	330K	253K	619K	-128K	1.63M	489K	1.04M	-24.85M
Working Capital Changes	975K	-518K	181K	-1.92M	894K	-1.73M	-4.58M	1.67M	-3.74M	1.19M
Change in Receivables	-1.2M	293K	-479K	-1.5M	-734K	623K	-874K	-367K	-2.51M	1.84M
Change in Inventory	1.08M	17K	606K	-113K	0	-303K	-1.41M	81K	24K	88K
Change in Payables	750K	-389K	38K	-208K	58K	339K	-234K	392K	-433K	-262K
Cash from Investing+	996K	-814K	-968K	-843K	-1.7M	-1.01M	-825K	-26.84M	18.4M	-189.98M
Capital Expenditures	-1.1M	-814K	-971K	-844K	-1.7M	-758K	-825K	-2.16M	-828K	-51K
CapEx % of Revenue	0.16%	0.11%	0.08%	0.04%	0.05%	0.02%	0.02%	0.04%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	2.1M	-591K	3K	1K	0	-248K	0	0	-1M	-189.43M
Cash from Financing+	-612K	2.83M	1.18M	-2.03M	-6.57M	230K	13K	-4.94M	-1.9M	117.19M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	14K	0	739K	870K	0	230K	13K	54K	0	-2.41M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-5.24M	-2.62M	-350K	3.85M	11.03M	14.36M	15.23M	15.3M	16.99M	-165.34M
FCF Margin %	-0.75%	-0.35%	-0.03%	0.18%	0.34%	0.37%	0.29%	0.27%	0.25%	-2.94%
FCF Growth %	-0.23%	0.5%	0.87%	12.01%	1.86%	0.3%	0.06%	0%	0.11%	-10.73%
FCF per Share	-1.06	-0.51	-0.06	0.51	1.37	1.78	1.87	1.91	2.17	-20.72
FCF Conversion (FCF/Net Income)	0.49x	0.71x	-0.41x	0.94x	0.84x	1.08x	0.93x	1.22x	0.87x	0.60x
Interest Paid	0	0	0	575K	0	0	0	0	0	0
Taxes Paid	0	0	0	18K	0	285K	2.65M	2.4M	0	2.26M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-719.2%	-	-	621.7%	174.69%	65.35%	45.72%	28.3%	32.29%	27.04%
Return on Invested Capital (ROIC)	-	-	-	439.31%	257.24%	183.52%	179.35%	62.25%	70.04%	13.26%
Gross Margin	59.33%	74.8%	79.5%	87.42%	88.83%	91.31%	88.45%	92.5%	89.76%	91.55%
Net Margin	-121.43%	-34.36%	-12.13%	23.33%	46.03%	36.28%	32.48%	25.27%	30.19%	72.65%
Debt / Equity	-	-	-	-	-	-	0.01x	0.00x	0.00x	0.00x
Interest Coverage	-97.90x	-5.52x	-1.84x	17.93x	-	-	-	-	-	-
FCF Conversion	0.49x	0.71x	-0.41x	0.94x	0.84x	1.08x	0.93x	1.22x	0.87x	0.60x
Revenue Growth	92.6%	6.18%	67.5%	72.59%	52.47%	17.81%	37.36%	6.9%	20.28%	-17.44%

Frequently Asked Questions

Valuation & Price

Semler Scientific, Inc. (SMLR) has a price-to-earnings (P/E) ratio of 4.0x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Semler Scientific, Inc. (SMLR) reported $37.0M in revenue for fiscal year 2024. This represents a 11595% increase from $0.3M in 2011.

Semler Scientific, Inc. (SMLR) saw revenue decline by 17.4% over the past year.

Yes, Semler Scientific, Inc. (SMLR) is profitable, generating $48.3M in net income for fiscal year 2024 (72.7% net margin).

Dividend & Returns

Semler Scientific, Inc. (SMLR) has a return on equity (ROE) of 27.0%. This is excellent, indicating efficient use of shareholder capital.

Semler Scientific, Inc. (SMLR) had negative free cash flow of $388.7M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Semler Scientific, Inc. (SMLR) 10-Year Financial Performance & Capital Metrics

SMLR • • Industrial / General

HealthcareMedical DevicesDiagnostic & Imaging EquipmentPoint-of-Care Diagnostics

Revenue $56M -17.4%
EBITDA $22M -5.9%
Net Income $41M +98.7%
EPS (Diluted) 5.13 +95.1%
Gross Margin 91.55% +2.0%
EBITDA Margin 38.21% +14.0%
Operating Margin 37.19% +13.9%
Net Margin 72.65% +140.7%
ROE 27.04% -16.3%
ROIC 13.26% -81.1%
Debt/Equity 0.00 -86.4%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 29.2%
✓Strong 5Y profit CAGR of 22.1%
✓Strong 5Y sales CAGR of 11.4%
✓Healthy 5Y average net margin of 39.4%
✓Trading at only 0.7x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 12 (bottom 12%)
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y31.52%

5Y11.43%

3Y2.01%

TTM-37.29%

Profit (Net Income) CAGR

10Y-

5Y22.08%

3Y33.42%

TTM203.75%

EPS CAGR

10Y-

5Y22.23%

3Y34.25%

TTM35.52%

ROCE

10Y Avg-5.61%

5Y Avg41.51%

3Y Avg27.47%

Latest13.71%

Peer Comparison

Point-of-Care Diagnostics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
PAVMPAVmed Inc.	8.06M	8.75	17.64	22.15%	-217914.55%	-245.07%
SMLRSemler Scientific, Inc.	310.75M	20.33	3.96	-17.44%	130.8%	10.51%	0.00
BJDXBluejay Diagnostics, Inc.	1.18M	0.65	-0.02			-185.51%	0.04
HSCSHeartSciences Inc.	10.17M	3.20	-0.34	-76.61%	-1042.38%	-216.05%	14.55
LUCDLucid Diagnostics Inc.	163.87M	1.25	-1.19	79%	-8.6%	-404.1%	3.94
BMRABiomerica, Inc.	8.09M	2.68	-1.24	-1.92%	-90.29%	-90.76%	0.11
MDAISpectral AI, Inc.	49.41M	1.61	-1.89	63.83%	-70.64%
CODXCo-Diagnostics, Inc.	6.12M	2.92	-2.35	-42.53%	-63.36%	-80.8%	0.04

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	7M	7.43M	12.45M	21.49M	32.77M	38.6M	53.03M	56.69M	68.18M	56.29M
Revenue Growth %	0.93%	0.06%	0.68%	0.73%	0.52%	0.18%	0.37%	0.07%	0.2%	-0.17%
Cost of Goods Sold+	2.85M	1.87M	2.55M	2.7M	3.66M	3.36M	6.12M	4.25M	6.98M	4.76M
COGS % of Revenue	0.41%	0.25%	0.21%	0.13%	0.11%	0.09%	0.12%	0.08%	0.1%	0.08%
Gross Profit+	4.15M	5.56M	9.9M	18.79M	29.11M	35.25M	46.91M	52.43M	61.2M	51.53M
Gross Margin %	0.59%	0.75%	0.79%	0.87%	0.89%	0.91%	0.88%	0.92%	0.9%	0.92%
Gross Profit Growth %	0.41%	0.34%	0.78%	0.9%	0.55%	0.21%	0.33%	0.12%	0.17%	-0.16%
Operating Expenses+	12.57M	7.72M	10.75M	13.45M	18.4M	19.29M	27.46M	35.23M	38.94M	30.6M
OpEx % of Revenue	1.8%	1.04%	0.86%	0.63%	0.56%	0.5%	0.52%	0.62%	0.57%	0.54%
Selling, General & Admin	11.14M	6.85M	8.92M	11.36M	15.92M	16.35M	23.68M	30.42M	32.44M	25.81M
SG&A % of Revenue	1.59%	0.92%	0.72%	0.53%	0.49%	0.42%	0.45%	0.54%	0.48%	0.46%
Research & Development	1.44M	866K	1.83M	2.08M	2.48M	2.94M	3.78M	4.81M	5.77M	4.79M
R&D % of Revenue	0.21%	0.12%	0.15%	0.1%	0.08%	0.08%	0.07%	0.08%	0.08%	0.09%
Other Operating Expenses	-82K	0	-14K	-4K	-9K	0	0	0	734K	0
Operating Income+	-8.42M	-2.16M	-853K	5.34M	10.71M	15.96M	19.45M	17.2M	22.26M	20.93M
Operating Margin %	-1.2%	-0.29%	-0.07%	0.25%	0.33%	0.41%	0.37%	0.3%	0.33%	0.37%
Operating Income Growth %	-0.94%	0.74%	0.6%	7.26%	1%	0.49%	0.22%	-0.12%	0.29%	-0.06%
EBITDA+	-8.1M	-1.71M	-294K	5.84M	11.34M	16.54M	20.07M	17.79M	22.86M	21.51M
EBITDA Margin %	-1.16%	-0.23%	-0.02%	0.27%	0.35%	0.43%	0.38%	0.31%	0.34%	0.38%
EBITDA Growth %	-0.96%	0.79%	0.83%	20.88%	0.94%	0.46%	0.21%	-0.11%	0.28%	-0.06%
D&A (Non-Cash Add-back)	315K	452K	559K	503K	632K	577K	622K	589K	599K	579K
EBIT	-8.41M	-2.16M	-1.05M	5.34M	10.71M	16.49M	19.45M	17.2M	22.99M	20.93M
Net Interest Income+	-86K	-391K	-464K	-298K	2K	19K	10K	494K	2.47M	1.88M
Interest Income	0	0	0	0	2K	19K	10K	494K	2.47M	1.88M
Interest Expense	86K	391K	464K	298K	0	0	0	0	0	0
Other Income/Expense	-82K	-395K	-657K	-302K	-7K	525K	10K	489K	1.84M	26.95M
Pretax Income+	-8.5M	-2.55M	-1.51M	5.04M	10.7M	16.49M	19.45M	17.69M	24.1M	47.88M
Pretax Margin %	-1.21%	-0.34%	-0.12%	0.23%	0.33%	0.43%	0.37%	0.31%	0.35%	0.85%
Income Tax+	0	0	0	26K	-4.38M	2.48M	2.23M	3.37M	3.52M	6.99M
Effective Tax Rate %	1%	1%	1%	0.99%	1.41%	0.85%	0.89%	0.81%	0.85%	0.85%
Net Income+	-8.5M	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M
Net Margin %	-1.21%	-0.34%	-0.12%	0.23%	0.46%	0.36%	0.32%	0.25%	0.3%	0.73%
Net Income Growth %	-0.88%	0.7%	0.41%	4.32%	2.01%	-0.07%	0.23%	-0.17%	0.44%	0.99%
Net Income (Continuing)	-8.5M	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-1.72	-0.50	-0.28	0.66	1.88	1.74	2.12	1.79	2.63	5.13
EPS Growth %	-0.56%	0.71%	0.44%	3.36%	1.85%	-0.07%	0.22%	-0.16%	0.47%	0.95%
EPS (Basic)	-1.72	-0.50	-0.28	0.66	2.34	2.13	2.56	2.13	3.06	5.66
Diluted Shares Outstanding	4.93M	5.12M	5.41M	7.63M	8.03M	8.07M	8.14M	8M	7.82M	7.98M
Basic Shares Outstanding	4.93M	5.12M	5.39M	7.6M	6.44M	6.58M	6.73M	6.73M	6.73M	7.23M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.75M	1.59M	2.88M	6.24M	11.44M	26.6M	45.54M	48.91M	65.94M	22.69M
Cash & Short-Term Investments	405K	622K	1.46M	3.28M	7.74M	22.08M	37.32M	43.09M	57.2M	14.92M
Cash Only	405K	622K	1.46M	3.28M	7.74M	22.08M	37.32M	23.01M	57.2M	8.82M
Short-Term Investments	0	0	0	0	0	0	0	20.07M	0	6.1M
Accounts Receivable	1.28M	877K	1.31M	2.8M	3.49M	2.81M	3.62M	3.88M	6.13M	4.38M
Days Sales Outstanding	66.63	43.06	38.55	47.57	38.83	26.55	24.91	25.01	32.79	28.39
Inventory	-1.28M	-877K	-1.31M	-2.8M	0	340K	550K	469K	445K	358K
Days Inventory Outstanding	-	-	-	-	-	36.98	32.79	40.26	23.26	27.46
Other Current Assets	0	0	0	0	0	0	0	0	2.17M	3.03M
Total Non-Current Assets+	1.33M	1.48M	1.35M	1.48M	6.84M	8.04M	5.14M	13.79M	12.12M	217.14M
Property, Plant & Equipment	1.33M	1.47M	1.34M	1.47M	2.33M	2.2M	2.04M	3.15M	3M	1.91M
Fixed Asset Turnover	5.28x	5.07x	9.29x	14.66x	14.08x	17.53x	26.03x	18.02x	22.69x	29.47x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	214.63M
Long-Term Investments	0	0	0	0	0	3.05M	821K	5.5M	5.88M	512K
Other Non-Current Assets	0	15K	15K	15K	15K	418K	332K	2.84M	270K	85K
Total Assets+	3.08M	3.07M	4.24M	7.72M	18.29M	34.64M	50.67M	62.69M	78.06M	239.83M
Asset Turnover	2.27x	2.42x	2.94x	2.78x	1.79x	1.11x	1.05x	0.90x	0.87x	0.23x
Asset Growth %	-0.59%	-0%	0.38%	0.82%	1.37%	0.89%	0.46%	0.24%	0.25%	2.07%
Total Current Liabilities+	4.11M	3.23M	5.14M	3.51M	5.21M	4.51M	4.88M	6.86M	6.2M	6.31M
Accounts Payable	839K	450K	488K	280K	338K	677K	443K	835K	402K	140K
Days Payables Outstanding	107.56	87.69	69.77	37.81	33.7	73.63	26.41	71.68	21.01	10.74
Short-Term Debt	0	81K	1.25M	0	0	0	0	0	0	0
Deferred Revenue (Current)	952K	513K	531K	435K	955K	963K	921K	1000K	1000K	774K
Other Current Liabilities	1.09M	704K	591K	355K	1.04M	1.6M	523K	2.5M	2.09M	3.9M
Current Ratio	0.43x	0.49x	0.56x	1.78x	2.20x	5.89x	9.33x	7.13x	10.64x	3.59x
Quick Ratio	0.74x	0.76x	0.82x	2.57x	2.20x	5.82x	9.22x	7.06x	10.56x	3.54x
Cash Conversion Cycle	-	-	-	-	-	-10.1	31.29	-6.41	35.04	45.11
Total Non-Current Liabilities+	43K	2.76M	1.68M	11K	7K	332K	245K	160K	70K	2.77M
Long-Term Debt	0	2.53M	1.67M	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	245K	160K	70K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	2.77M
Other Non-Current Liabilities	43K	230K	13K	11K	7K	332K	0	0	0	0
Total Liabilities	4.15M	5.99M	6.82M	3.52M	5.21M	4.85M	5.13M	7.02M	6.27M	9.08M
Total Debt+	0	2.61M	2.92M	0	0	0	325K	245K	160K	70K
Net Debt	-405K	1.99M	1.47M	-3.28M	-7.74M	-22.08M	-37M	-22.77M	-57.04M	-8.75M
Debt / Equity	-	-	-	-	-	-	0.01x	0.00x	0.00x	0.00x
Debt / EBITDA	-	-	-	-	-	-	0.02x	0.01x	0.01x	0.00x
Net Debt / EBITDA	-	-	-	-0.56x	-0.68x	-1.34x	-1.84x	-1.28x	-2.50x	-0.41x
Interest Coverage	-97.90x	-5.52x	-1.84x	17.93x	-	-	-	-	-	-
Total Equity+	-1.07M	-2.92M	-2.58M	4.2M	13.07M	29.79M	45.55M	55.68M	71.8M	230.75M
Equity Growth %	-1.31%	-1.72%	0.12%	2.62%	2.12%	1.28%	0.53%	0.22%	0.29%	2.21%
Book Value per Share	-0.22	-0.57	-0.48	0.55	1.63	3.69	5.60	6.96	9.18	28.92
Total Shareholders' Equity	-1.07M	-2.92M	-2.58M	4.2M	13.07M	29.79M	45.55M	55.68M	71.8M	230.75M
Common Stock	5K	5K	6K	6K	7K	7K	7K	7K	7K	9K
Retained Earnings	-22.37M	-24.92M	-26.43M	-21.42M	-6.33M	7.67M	24.89M	39.22M	59.8M	100.7M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-495K	-656K	-829K	-234K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-4.13M	-1.8M	621K	4.7M	12.73M	15.11M	16.06M	17.46M	17.82M	24.41M
Operating CF Margin %	-0.59%	-0.24%	0.05%	0.22%	0.39%	0.39%	0.3%	0.31%	0.26%	0.43%
Operating CF Growth %	-0.08%	0.56%	1.34%	6.56%	1.71%	0.19%	0.06%	0.09%	0.02%	0.37%
Net Income	-8.5M	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M
Depreciation & Amortization	315K	452K	559K	503K	632K	576K	628K	589K	599K	579K
Stock-Based Compensation	2.6M	300K	343K	601K	0	253K	749K	741K	0	862K
Deferred Taxes	416K	331K	718K	246K	-4.5M	2.14M	408K	-351K	-664K	5.73M
Other Non-Cash Items	55K	185K	330K	253K	619K	-128K	1.63M	489K	1.04M	-24.85M
Working Capital Changes	975K	-518K	181K	-1.92M	894K	-1.73M	-4.58M	1.67M	-3.74M	1.19M
Change in Receivables	-1.2M	293K	-479K	-1.5M	-734K	623K	-874K	-367K	-2.51M	1.84M
Change in Inventory	1.08M	17K	606K	-113K	0	-303K	-1.41M	81K	24K	88K
Change in Payables	750K	-389K	38K	-208K	58K	339K	-234K	392K	-433K	-262K
Cash from Investing+	996K	-814K	-968K	-843K	-1.7M	-1.01M	-825K	-26.84M	18.4M	-189.98M
Capital Expenditures	-1.1M	-814K	-971K	-844K	-1.7M	-758K	-825K	-2.16M	-828K	-51K
CapEx % of Revenue	0.16%	0.11%	0.08%	0.04%	0.05%	0.02%	0.02%	0.04%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	2.1M	-591K	3K	1K	0	-248K	0	0	-1M	-189.43M
Cash from Financing+	-612K	2.83M	1.18M	-2.03M	-6.57M	230K	13K	-4.94M	-1.9M	117.19M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	14K	0	739K	870K	0	230K	13K	54K	0	-2.41M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-5.24M	-2.62M	-350K	3.85M	11.03M	14.36M	15.23M	15.3M	16.99M	-165.34M
FCF Margin %	-0.75%	-0.35%	-0.03%	0.18%	0.34%	0.37%	0.29%	0.27%	0.25%	-2.94%
FCF Growth %	-0.23%	0.5%	0.87%	12.01%	1.86%	0.3%	0.06%	0%	0.11%	-10.73%
FCF per Share	-1.06	-0.51	-0.06	0.51	1.37	1.78	1.87	1.91	2.17	-20.72
FCF Conversion (FCF/Net Income)	0.49x	0.71x	-0.41x	0.94x	0.84x	1.08x	0.93x	1.22x	0.87x	0.60x
Interest Paid	0	0	0	575K	0	0	0	0	0	0
Taxes Paid	0	0	0	18K	0	285K	2.65M	2.4M	0	2.26M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-719.2%	-	-	621.7%	174.69%	65.35%	45.72%	28.3%	32.29%	27.04%
Return on Invested Capital (ROIC)	-	-	-	439.31%	257.24%	183.52%	179.35%	62.25%	70.04%	13.26%
Gross Margin	59.33%	74.8%	79.5%	87.42%	88.83%	91.31%	88.45%	92.5%	89.76%	91.55%
Net Margin	-121.43%	-34.36%	-12.13%	23.33%	46.03%	36.28%	32.48%	25.27%	30.19%	72.65%
Debt / Equity	-	-	-	-	-	-	0.01x	0.00x	0.00x	0.00x
Interest Coverage	-97.90x	-5.52x	-1.84x	17.93x	-	-	-	-	-	-
FCF Conversion	0.49x	0.71x	-0.41x	0.94x	0.84x	1.08x	0.93x	1.22x	0.87x	0.60x
Revenue Growth	92.6%	6.18%	67.5%	72.59%	52.47%	17.81%	37.36%	6.9%	20.28%	-17.44%

Frequently Asked Questions

Valuation & Price

Semler Scientific, Inc. (SMLR) has a price-to-earnings (P/E) ratio of 4.0x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Semler Scientific, Inc. (SMLR) reported $37.0M in revenue for fiscal year 2024. This represents a 11595% increase from $0.3M in 2011.

Semler Scientific, Inc. (SMLR) saw revenue decline by 17.4% over the past year.

Yes, Semler Scientific, Inc. (SMLR) is profitable, generating $48.3M in net income for fiscal year 2024 (72.7% net margin).

Dividend & Returns

Semler Scientific, Inc. (SMLR) has a return on equity (ROE) of 27.0%. This is excellent, indicating efficient use of shareholder capital.

Semler Scientific, Inc. (SMLR) had negative free cash flow of $388.7M in fiscal year 2024, likely due to heavy capital investments.